Search

Your search keyword '"Latella, Caterina"' showing total 19 results
Start Over Author "Latella, Caterina"
19 results on '"Latella, Caterina"'

7. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

Author

Franchini, Massimo, Castaman, Giancarlo, Coppola, Antonio, Santoro, Cristina, Zanon, Ezio, Di Minno, Giovanni, Morfini, Massimo, Santagostino, Elena, Rocino, Angiola, Abbate, Rosanna, Aru, Anna Brigida, Biasoli, Chiara, Borchiellini, Alessandra, Caimi, Teresa Maria, Cantori, Isabella, Cerbone, Anna Maria, Cesaro, Simone, Ciabatta, Carlo, Coluccia, Antonella, Contino, Laura, Cultrera, Dorina, De Cristofaro, Raimondo, Delios, Grazia, Di Minno, Matteo Nicola Dario, Dragani, Alfredo, Ettorre, Cosimo Pietro, Feola, Giulio, Gamba, Gabriella, Gandini, Giorgio, Giuffrida, Anna Chiara, Giuffrida, Gaetano, Gresele, Paolo, Hassan, Hamisa Jane, Lassandro, Giuseppe, Latella, Caterina, Linari, Silvia, Luciani, Matteo, Mancuso, Maria Elisa, Marchesini, Emanuela, Marino, Renato, Matino, Davide, Mazzucconi, Maria Gabriella, Messina, Maria, Milan, Marta, Molinari, Angelo Claudio, Napolitano, Mariasanta, Notarangelo, Lucia Dora, Peyvandi, Flora, Pollio, Berardino, Radossi, Paolo, Riccardi, Federica, Riva, Silvia, Rivolta, Gianna Franca, Rossetti, Gina, Santoro, Rita Carlotta, Serino, Maria Luisa, Schiavulli, Michele, Schiavoni, Mario, Schinco, Piercarla, Solimeno, Luigi Piero, Sottilotta, Gianluca, Targhetta, Roberto, Tagliaferri, Annarita, Testa, Sophie, Todisco, Angela, Turello, Marina, Valdrè, Lelia, Franchini M., Castaman G., Coppola A., Santoro C., Zanon E., Di Minno G., Morfini M., Santagostino E., Rocino A., Abbate R., Aru A.B., Biasoli C., Borchiellini A., Caimi T.M., Cantori I., Cerbone A.M., Cesaro S., Ciabatta C., Coluccia A., Contino L., Cultrera D., De Cristofaro R., Delios G., Di Minno M.N.D., Dragani A., Ettorre C.P., Feola G., Gamba G., Gandini G., Giuffrida A.C., Giuffrida G., Gresele P., Hassan H.J., Lassandro G., Latella C., Linari S., Luciani M., Mancuso M.E., Marchesini E., Marino R., Matino D., Mazzucconi M.G., Messina M., Milan M., Molinari A.C., Napolitano M., Notarangelo L.D., Peyvandi F., Pollio B., Radossi P., Riccardi F., Riva S., Rivolta G.F., Rossetti G., Santoro R.C., Serino M.L., Schiavulli M., Schiavoni M., Schinco P., Solimeno L.P., Sottilotta G., Targhetta R., Tagliaferri A., Testa S., Todisco A., Turello M., Valdre L., Franchini, Massimo, Castaman, Giancarlo, Coppola, Antonio, Santoro, Cristina, Zanon, Ezio, DI MINNO, Giovanni, Morfini, Massimo, Santagostino, Elena, Rocino, Angiola, Group Author: Abbate, Rosanna, Aru, Anna Brigida, Biasoli, Chiara, Borchiellini, Alessandra, Caimi, Teresa Maria, Cantori, Isabella, Cerbone, Anna Maria, Cesaro, Simone, Ciabatta, Carlo, Coluccia, Antonella, Contino, Laura, Cultrera, Dorina, De Cristofaro, Raimondo, Delios, Grazia, DI MINNO, matteo nicola dario, Dragani, Alfredo, Ettorre, Cosimo Pietro, Feola, Giulio, Gamba, Gabriella, Gandini, Giorgio, Giuffrida, Anna Chiara, Giuffrida, Gaetano, Gresele, Paolo, Hassan, Hamisa Jane, Lassandro, Giuseppe, Latella, Caterina, Linari, Silvia, Luciani, Matteo, Mancuso, Maria Elisa, Marchesini, Emanuela, Marino, Renato, Matino, Davide, Mazzucconi, Maria Gabriella, Messina, Maria, Milan, Marta, Molinari, Angelo Claudio, Napolitano, Mariasanta, Notarangelo, Lucia Dora, Peyvandi, Flora, Pollio, Berardino, Radossi, Paolo, Riccardi, Federica, Riva, Silvia, Rivolta, Gianna Franca, Rossetti, Gina, Santoro, Rita Carlotta, Serino, Maria Luisa, Schiavulli, Michele, Schiavoni, Mario, Schinco, Piercarla, Solimeno, Luigi Piero, Sottilotta, Gianluca, Targhetta, Roberto, Tagliaferri, Annarita, Testa, Sophie, Todisco, Angela, Turello, Marina, and Valdrè, Lelia

Subjects
Male, Autoantibodies, Blood Coagulation Factor Inhibitors, Female, Humans, Hemophilia A, Immunology and Allergy, Hematology, Blood Coagulation Factor Inhibitor, Recommendation, Autoantibodie, Human
Published
2015

11. Early urinary aldosterone excretion in very low birth weight infants

Author

Costa, Simonetta, Cota, Francesco, Romagnoli, Costantino, Latella, Caterina, Maggio, Luca, Tesfagabir, Mg, Gallini, Francesca, Cota, Francesco (ORCID:0000-0002-9009-3997), Romagnoli, Costantino (ORCID:0000-0003-1176-2943), Maggio, Luca (ORCID:0000-0001-6358-7775), Gallini, Francesca (ORCID:0000-0002-9510-8481), Costa, Simonetta, Cota, Francesco, Romagnoli, Costantino, Latella, Caterina, Maggio, Luca, Tesfagabir, Mg, Gallini, Francesca, Cota, Francesco (ORCID:0000-0002-9009-3997), Romagnoli, Costantino (ORCID:0000-0003-1176-2943), Maggio, Luca (ORCID:0000-0001-6358-7775), and Gallini, Francesca (ORCID:0000-0002-9510-8481)

Abstract

INTRODUCTION: : In the neonatal period, many factors may interfere with aldosterone production but data currently available are few and controversial. In this study we aim to assess the early urinary aldosterone excretion (UAE) in very low birth weight (VLBW) infants and to identify some possible clinical and biochemical variables that may influence this excretion. MATERIALS AND METHODS: : We conducted a prospective study in 30 VLBW infants. Aldosterone was measured in the first 72 hours of life in the urine and plasma and urinary electrolytes were determined. Demographic and clinical data were also recorded. RESULTS: : The exploratory analysis showed that a significant positive correlation exists between UAE and gestational age and birth weight and that infants with respiratory distress syndrome have higher urinary aldosterone levels than infants without respiratory distress, but only plasma sodium resulted a significant independent factor that negatively influenced UAE at linear regression analysis (coefficient -0.02, 95% confidence interval [-0.03; -0.004]; adjusted R (2) 0.33). CONCLUSIONS: : The renin-angiotensin-aldosterone system of VLBW infants seems to be able, even immediately after birth, to respond to variations of plasma sodium concentrations; measurement of UAE constitutes an interesting method to determine aldosterone production, avoiding blood sampling in neonates so small and frail as VLBW infants.

Published
2012

12. Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low birth weight infants.

Author

Costa, Simonetta, Cota, Francesco, Romagnoli, Costantino, Latella, Caterina, Maggio, Luca, Gallini, Francesca, Cota, Francesco (ORCID:0000-0002-9009-3997), Romagnoli, Costantino (ORCID:0000-0003-1176-2943), Maggio, Luca (ORCID:0000-0001-6358-7775), Gallini, Francesca (ORCID:0000-0002-9510-8481), Costa, Simonetta, Cota, Francesco, Romagnoli, Costantino, Latella, Caterina, Maggio, Luca, Gallini, Francesca, Cota, Francesco (ORCID:0000-0002-9009-3997), Romagnoli, Costantino (ORCID:0000-0003-1176-2943), Maggio, Luca (ORCID:0000-0001-6358-7775), and Gallini, Francesca (ORCID:0000-0002-9510-8481)

Abstract

Background. It has been reported that the renin-angiotensin-aldosterone system (RAAS) of healthy newborn infants and preterm infants responds to acute furosemide challenge. Objective. To assess urinary aldosterone excretion (UAE) and electrolytic balance (EB) in very low-birth weight (VLBW) infants who received chronic therapy with furosemide and to compare them with those of infants who did not receive diuretic therapy. Methods. Infants with birth weight <1500 grams were considered eligible for this prospective observational study. On the 10th day of life, infants enrolled were divided in two groups on the basis of our predictive score for chronic lung disease (CLD): group 1, with positive score, received furosemide and group 2, with negative score, did not receive diuretic therapy. Urinary aldosterone and electrolytes excretion, electrolytes intakes and clearance of creatinine were investigated before the beginning of the treatment and then weekly until discharge in both groups, and results were compared. Results. Thirty infants were studied: fifteen received long-term furosemide and fifteen did not. UAE progressively increased in infants who received furosemide whereas remained unchanged in infants who did not receive treatment. UAE was greater in group 1 than in group 2 after three weeks of diuretic treatment, reaching statistical significance after four weeks of treatment. Conclusions. In VLBW infants chronic therapy with furosemide leads to a progressive increase in UAE, that may potentially limit the diuretic effect of long-term use of furosemide in the management of CLD.

Published
2011

13. Could early serum bilirubin measurement be useful in predicting non physiologic hyperbilirubinemia

Author

Romagnoli, Costantino, De Luca, Daniele, Zuppa, Antonio Alberto, Parenti, Dante, Latella, Caterina, Romagnoli, Costantino (ORCID:0000-0003-1176-2943), Zuppa, Antonio Alberto (ORCID:0000-0001-8139-2576), Romagnoli, Costantino, De Luca, Daniele, Zuppa, Antonio Alberto, Parenti, Dante, Latella, Caterina, Romagnoli, Costantino (ORCID:0000-0003-1176-2943), and Zuppa, Antonio Alberto (ORCID:0000-0001-8139-2576)

Published
2005

18. Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

Author

Franchini M, Coppola A, Rocino A, Zanon E, Morfini M, Accorsi A, Aru AB, Biasoli C, Cantori I, Castaman G, Cesaro S, Ciabatta C, De Cristofaro R, Delios G, Di Minno G, D'Incà M, Dragani A, Ettorre CP, Gagliano F, Gamba G, Gandini G, Giordano P, Giuffrida G, Gresele P, Latella C, Luciani M, Margaglione M, Marietta M, Mazzucconi MG, Messina M, Molinari AC, Notarangelo LD, Oliovecchio E, Peyvandi F, Piseddu G, Rossetti G, Rossi V, Santagostino E, Schiavoni M, Schinco P, Serino ML, Tagliaferri A, and Testa S

Subjects
Blood Coagulation Factors therapeutic use, Health Care Surveys, Hemophilia A drug therapy, Humans, Italy, Surveys and Questionnaires, Hemophilia A epidemiology, Hospitals, Special, Medical Staff, Hospital, Practice Patterns, Physicians' statistics & numerical data
Abstract

Despite great advances in haemophilia care in the last 20 years, a number of questions on haemophilia therapy remain unanswered. These debated issues primarily involve the choice of the product type (plasma-derived vs. recombinant) for patients with different characteristics: specifically, if they were infected by blood-borne virus infections, and if they bear high or low risk of inhibitor development. In addition, the most appropriate treatment regimen in non-inhibitor and inhibitor patients compel physicians operating at the haemophilia treatment centres (HTCs) to take important therapeutic decisions, which are often based on their personal clinical experience rather than on evidence-based recommendations from published literature data. To know the opinion on the most controversial aspects in haemophilia care of Italian expert physicians, who are responsible for common clinical practice and therapeutic decisions, we have conducted a survey among the Directors of HTCs affiliated to the Italian Association of Haemophilia Centres (AICE). A questionnaire, consisting of 19 questions covering the most important topics related to haemophilia treatment, was sent to the Directors of all 52 Italian HTCs. Forty Directors out of 52 (76.9%) responded, accounting for the large majority of HTCs affiliated to the AICE throughout Italy. The results of this survey provide for the first time a picture of the attitudes towards clotting factor concentrate use and product selection of clinicians working at Italian HTCs., (© 2014 John Wiley & Sons Ltd.)

Published
2014
Full Text
View/download PDF

19. Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.

Author

Giampaolo A, Abbonizio F, Puopolo M, Arcieri R, Mannucci PM, Hassan HJ, Accorsi A, Ettorre PC, Schiavoni M, Palareti G, Rodorigo G, Valdré L, Amaddii G, Billio A, Notarangelo L, Iannacaro P, Muleo P, Biasioli C, Rossi V, Alatri A, Testa S, Vincenzi D, Scapoli G, Morfini M, Molinari AC, Lapecorella M, Mariani G, Baudo F, Caimi MT, Federici AB, Gringeri A, Mannucci PM, Santagostino E, Marietta M, Coppola A, Di Minno G, Perricone C, Schiavulli M, Miraglia E, Rocino A, Zanon E, Gagliano F, Mancuso G, Siragusa S, Rivolta F, Tagliaferri A, Gamba G, Iorio A, Oliovecchio E, Dragani A, Arbasi MC, Albertini P, Mancino A, Lombardo VT, Latella C, D'Incà M, Landolfi Raffaele, Biondo Francesca, Mazzucconi MG, Santoro Cristina, Mameli AL, Piseddu G, Schinco PC, Messina M, Rossetti G, Barillari G, Feola G, Franchini M, Gandini G, Castaman G, and Rodeghiero F

Subjects
Female, Humans, Italy, Male, Surveys and Questionnaires, Factor IX administration & dosage, Factor IX economics, Factor VIII administration & dosage, Factor VIII economics, Hemophilia A economics, Hemophilia A prevention & control, Hemophilia B economics, Hemophilia B prevention & control
Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results